{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:19:41Z","timestamp":1775042381654,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,1]]},"DOI":"10.7759\/cureus.106257","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T09:42:39Z","timestamp":1775036559000},"source":"Crossref","is-referenced-by-count":0,"title":["Managing Abnormal Uterine Bleeding With Norethisterone Acetate: An Evidence-Based Review and Expert Insights"],"prefix":"10.7759","author":[{"given":"Hema","family":"Divakar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjula","family":"Anagani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parikshit","family":"Tank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukanta","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayam","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girija","family":"Wagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitra","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farendra","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayita","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onkar C","family":"Swami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neeraj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2024-4-1","article-title":"Effect of norethisterone dose and duration in the management of abnormal uterine bleeding: a narrative review and case report","volume":"13","author":"Boruah AM","year":"2024","unstructured":"Boruah AM, Banerjee D, Bhardwaj F, Mallya S, Singal R, Sharma S, Gautam A. Effect of norethisterone dose and duration in the management of abnormal uterine bleeding: a narrative review and case report. Drugs Context. 2024, 13:2024-4-1. 10.7573\/dic.2024-4-1","journal-title":"Drugs Context"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.26502\/ogr022","article-title":"Abnormal uterine bleeding: a doctor centric survey on prevalence, management and limitations in Indian context","volume":"2","author":"Faruqui AA","year":"2019","unstructured":"Faruqui AA. Abnormal uterine bleeding: a doctor centric survey on prevalence, management and limitations in Indian context. Obstet Gynecol Res. 2019, 2:059-066. 10.26502\/ogr022","journal-title":"Obstet Gynecol Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.21276\/obgyn.2020.7.11","article-title":"Abnormal uterine bleeding; its prevalence, causes and management in a tertiary care hospital","volume":"7","author":"Choudhury SA","year":"2020","unstructured":"Choudhury SA, Nath P. Abnormal uterine bleeding; its prevalence, causes and management in a tertiary care hospital. New Indian J OBGYN. 2020, 7:52-7. 10.21276\/obgyn.2020.7.11","journal-title":"New Indian J OBGYN"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2022\/59994.17252","article-title":"Prevalence of abnormal uterine bleeding and its associated risk factors in women of perimenopausal age group-a retrospective study","volume":"16","author":"Vaidya R","year":"2022","unstructured":"Vaidya R, Vinayachandran S, Devi S, Prejisha B, G Lekshminath GL, Sreedharan S, Jahrin PK. Prevalence of abnormal uterine bleeding and its associated risk factors in women of perimenopausal age group-a retrospective study. J Clin Diagn Res. Published Online First. 2022, 16:QC09-13. 10.7860\/JCDR\/2022\/59994.17252","journal-title":"J Clin Diagn Res. Published Online First"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/0976-7800.109648","article-title":"Trends of AUB in tertiary centre of Shimla hills","volume":"4","author":"Sharma A","year":"2013","unstructured":"Sharma A, Dogra Y. Trends of AUB in tertiary centre of Shimla hills. J Midlife Health. 2013, 4:67-8. 10.4103\/0976-7800.109648","journal-title":"J Midlife Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.14947","article-title":"Therapeutic options for the management of abnormal uterine bleeding","volume":"162","author":"MacGregor B","year":"2023","unstructured":"MacGregor B, Munro MG, Lumsden MA. Therapeutic options for the management of abnormal uterine bleeding. Int J Gynaecol Obstet. 2023, 162:43-57. 10.1002\/ijgo.14947","journal-title":"Int J Gynaecol Obstet"},{"key":"ref7","article-title":"Abnormal uterine bleeding in premenopausal women","volume":"99","author":"Wouk N","year":"2019","unstructured":"Wouk N, Helton M. Abnormal uterine bleeding in premenopausal women. Am Fam Physician. 2019, 99:435-43.","journal-title":"Am Fam Physician"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2006.02.009","article-title":"Menstrual bleeding patterns following levonorgestrel emergency contraception","volume":"74","author":"Gainer E","year":"2006","unstructured":"Gainer E, Kenfack B, Mboudou E, Doh AS, Bouyer J. Menstrual bleeding patterns following levonorgestrel emergency contraception. Contraception. 2006, 74:118-24. 10.1016\/j.contraception.2006.02.009","journal-title":"Contraception"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.18231\/j.jpmhh.2020.009","article-title":"Increasing percentage of \u2018early menarche\u2019 in Indian adolescent girls and it\u2019s prevention","volume":"6","author":"Deshpande P","year":"2020","unstructured":"Deshpande P. Increasing percentage of \u2018early menarche\u2019 in Indian adolescent girls and it\u2019s prevention. J Prev Med Holist Health. 2020, 6:49-51. 10.18231\/j.jpmhh.2020.009","journal-title":"J Prev Med Holist Health"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/amhs.amhs_60_23","article-title":"Is metabolic syndrome a fellow traveler with abnormal uterine bleeding in women of reproductive age? A case-control study","volume":"11","author":"Balakrishnan G","year":"2023","unstructured":"Balakrishnan G, Tyagi M, Uppinakudru G, Thalanjeri P, Kaveri V, Balasubramaniyam K, Ali SI. Is metabolic syndrome a fellow traveler with abnormal uterine bleeding in women of reproductive age? A case-control study. Arch Med Health Sci. 2023, 11:44-8. 10.4103\/amhs.amhs_60_23","journal-title":"Arch Med Health Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.21150","article-title":"Rate of premalignant and malignant endometrial lesion in \"low-risk\" premenopausal women with abnormal uterine bleeding undergoing endometrial biopsy","volume":"64","author":"Jha S","year":"2021","unstructured":"Jha S, Singh A, Sinha HH, Bhadani P, Anant M, Agarwal M. Rate of premalignant and malignant endometrial lesion in \"low-risk\" premenopausal women with abnormal uterine bleeding undergoing endometrial biopsy. Obstet Gynecol Sci. 2021, 64:517-23. 10.5468\/ogs.21150","journal-title":"Obstet Gynecol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s41043-024-00540-4","article-title":"Contributing factors related to abnormal uterine bleeding in perimenopausal women: a case-control study","volume":"43","author":"Tian Y","year":"2024","unstructured":"Tian Y, Bai B, Wang L, Zhou Z, Tang J. Contributing factors related to abnormal uterine bleeding in perimenopausal women: a case-control study. J Health Popul Nutr. 2024, 43:52. 10.1186\/s41043-024-00540-4","journal-title":"J Health Popul Nutr"},{"key":"ref13","article-title":"Abnormal uterine bleeding","author":"Mikes BA","year":"2025","unstructured":"Mikes BA, Vadakekut ES, Sparzak PB. Abnormal uterine bleeding. StatPearls [Internet]. StatPearls Publishing, Treasure Island, USA; 2025."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s13224-016-0925-8","article-title":"FIGO's PALM-COEIN classification of abnormal uterine bleeding: a clinico-histopathological correlation in Indian setting","volume":"67","author":"Mishra D","year":"2017","unstructured":"Mishra D, Sultan S. FIGO's PALM-COEIN classification of abnormal uterine bleeding: a clinico-histopathological correlation in Indian setting. J Obstet Gynaecol India. 2017, 67:119-25. 10.1007\/s13224-016-0925-8","journal-title":"J Obstet Gynaecol India"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26015","article-title":"The clinical relevance of progestogens in hormonal contraception: present status and future developments","volume":"9","author":"Regidor PA","year":"2018","unstructured":"Regidor PA. The clinical relevance of progestogens in hormonal contraception: present status and future developments. Oncotarget. 2018, 9:34628-38. 10.18632\/oncotarget.26015","journal-title":"Oncotarget"},{"key":"ref16","unstructured":"Norethisterone 5mg tablets. Summary of product characteristics (SmPC). (2025). Accessed. November 26, 2025: https:\/\/www.medicines.org.uk\/emc\/product\/1494\/smpc#gref."},{"key":"ref17","unstructured":"Norethindrone acetate tablets USP, 5 mg. (2025). Accessed. November 26, 2025: https:\/\/dailymed.nlm.nih.gov\/dailymed\/fda\/fdaDrugXsl.cfm?setid=4e8e531a-dac2-44ce-b06b-390296c26833&type=display ."},{"key":"ref18","unstructured":"Primolut N. Norethisterone. (2025). Accessed.  November 26, 2025: https:\/\/www.nps.org.au\/medicine-finder\/primolut-n-tablets."},{"key":"ref19","unstructured":"Norethindrone acetate tablets U.S.P. tablets, 5 mg. Accessed. November 26, 2025: https:\/\/health-products.canada.ca\/dpd-bdpp\/info?lang=eng&code=1401."},{"key":"ref20","unstructured":"New drugs approved by CDSCO. (2025). Accessed. November 26, 2025: https:\/\/cdscoonline.gov.in\/CDSCO\/Drugs."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10006-2048","article-title":"Real-world safety and effectiveness analysis of norethisterone in the management of abnormal uterine bleeding","volume":"14","author":"Boruah AM","year":"2022","unstructured":"Boruah AM, Jaiswal P, Chinda M, Jaiswal A. Real-world safety and effectiveness analysis of norethisterone in the management of abnormal uterine bleeding. J South Asian Fed Obstet Gynaecol. 2022, 14:313-6. 10.5005\/jp-journals-10006-2048","journal-title":"J South Asian Fed Obstet Gynaecol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/jmr.2540","article-title":"Probing the binding of two 19-nortestosterone derivatives to human serum albumin: insights into the interactions of steroid hormone drugs with functional biomacromolecule","volume":"29","author":"He J","year":"2016","unstructured":"He J, Wang Q, Ma X, Yang H, Li S, Xu K, Li H. Probing the binding of two 19-nortestosterone derivatives to human serum albumin: insights into the interactions of steroid hormone drugs with functional biomacromolecule. J Mol Recognit. 2016, 29:415-25. 10.1002\/jmr.2540","journal-title":"J Mol Recognit"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsrh-2020-200619","article-title":"Norethisterone and its acetate - what's so special about them?","volume":"47","author":"Huvinen E","year":"2021","unstructured":"Huvinen E, Holopainen E, Heikinheimo O. Norethisterone and its acetate - what's so special about them?. BMJ Sex Reprod Health. 2021, 47:102-9. 10.1136\/bmjsrh-2020-200619","journal-title":"BMJ Sex Reprod Health"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-4804(03)00215-4","article-title":"The role of estrogen in cardiovascular disease","volume":"115","author":"Baker L","year":"2003","unstructured":"Baker L, Meldrum KK, Wang M, et al.. The role of estrogen in cardiovascular disease. J Surg Res. 2003, 115:325-44. 10.1016\/S0022-4804(03)00215-4","journal-title":"J Surg Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-017-0612-5","article-title":"The effects of progesterones on blood lipids in hormone replacement therapy","volume":"16","author":"Jiang Y","year":"2017","unstructured":"Jiang Y, Tian W. The effects of progesterones on blood lipids in hormone replacement therapy. Lipids Health Dis. 2017, 16:219. 10.1186\/s12944-017-0612-5","journal-title":"Lipids Health Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1515\/hmbci-2018-0033","article-title":"Choice of progestogen for endometrial protection in combination with transdermal estradiol in menopausal women","volume":"37","author":"Mueck AO","year":"2018","unstructured":"Mueck AO, R\u00f6mer T. Choice of progestogen for endometrial protection in combination with transdermal estradiol in menopausal women. Horm Mol Biol Clin Investig. 2018, 37:20180033. 10.1515\/hmbci-2018-0033","journal-title":"Horm Mol Biol Clin Investig"},{"key":"ref27","article-title":"Management Guidelines of Abnormal Uterine Bleeding in Reproductive Period. A Handbook of Evidence-Based Good Clinical Practice Recommendations - Indian Perspective","author":"Ganatra DA","year":"2016","unstructured":"Ganatra DA, Dhorepatil DB, Chandravati D, et al.. Management Guidelines of Abnormal Uterine Bleeding in Reproductive Period. A Handbook of Evidence-Based Good Clinical Practice Recommendations - Indian Perspective. Federation of Obstetric and Gynecological Societies of India, Mumbai; 2016."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(79)90715-4","article-title":"Pharmacokinetics of norethindrone acetate in women","volume":"135","author":"Singh H","year":"1979","unstructured":"Singh H, Uniyal JP, Jha P, Murugesan K, Takkar D, Hingorani V, Laumas KR. Pharmacokinetics of norethindrone acetate in women. Am J Obstet Gynecol. 1979, 135:409-14. 10.1016\/0002-9378(79)90715-4","journal-title":"Am J Obstet Gynecol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpag.2019.09.002","article-title":"The use of norethisterone for the treatment of severe uterine bleeding in adolescents: an audit of our experience","volume":"32","author":"Papapanagiotou IK","year":"2019","unstructured":"Papapanagiotou IK, Charamanta M, Roidi S, Al-Achmar NS, Soldatou A, Michala L. The use of norethisterone for the treatment of severe uterine bleeding in adolescents: an audit of our experience. J Pediatr Adolesc Gynecol. 2019, 32:596-9. 10.1016\/j.jpag.2019.09.002","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20200570","article-title":"Targeted treatments for dysfunctional uterine bleeding based on endometrial thickness","volume":"9","author":"Htwe TT","year":"2020","unstructured":"Htwe TT, Yi HH, Ku SK. Targeted treatments for dysfunctional uterine bleeding based on endometrial thickness. Int J Reprod Contracept Obstet Gynecol. 2020, 9:900-5. 10.18203\/2320-1770.ijrcog20200570","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2016.09.006","article-title":"Adenomyosis and abnormal uterine bleeding (AUB-A)\u2014pathogenesis, diagnosis, and management","volume":"40","author":"Abbott JA","year":"2017","unstructured":"Abbott JA. Adenomyosis and abnormal uterine bleeding (AUB-A)\u2014pathogenesis, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol. 2017, 40:68-81. 10.1016\/j.bpobgyn.2016.09.006","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/ph5101120","article-title":"Norethindrone acetate in the medical management of adenomyosis","volume":"5","author":"Muneyyirci-Delale O","year":"2012","unstructured":"Muneyyirci-Delale O, Chandrareddy A, Mankame S, Osei-Tutu N, Gizycki Hv. Norethindrone acetate in the medical management of adenomyosis. Pharmaceuticals (Basel). 2012, 5:1120-7. 10.3390\/ph5101120","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpag.2013.09.002","article-title":"Retrospective review of norethindrone use in adolescents","volume":"27","author":"Santos M","year":"2014","unstructured":"Santos M, Hendry D, Sangi-Haghpeykar H, Dietrich JE. Retrospective review of norethindrone use in adolescents. J Pediatr Adolesc Gynecol. 2014, 27:41-4. 10.1016\/j.jpag.2013.09.002","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2017.03.033","article-title":"Efficacy and acceptability of long-term norethindrone acetate for the treatment of rectovaginal endometriosis","volume":"213","author":"Morotti M","year":"2017","unstructured":"Morotti M, Venturini PL, Biscaldi E, et al.. Efficacy and acceptability of long-term norethindrone acetate for the treatment of rectovaginal endometriosis. Eur J Obstet Gynecol Reprod Biol. 2017, 213:4-10. 10.1016\/j.ejogrb.2017.03.033","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/442560-managing-abnormal-uterine-bleeding-with-norethisterone-acetate-an-evidence-based-review-and-expert-insights","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T09:42:42Z","timestamp":1775036562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/442560-managing-abnormal-uterine-bleeding-with-norethisterone-acetate-an-evidence-based-review-and-expert-insights"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.106257","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}